Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-01-26 @ 10:56 AM
Study NCT ID:
NCT01981161
Status:
COMPLETED
Last Update Posted:
2020-08-25
First Post:
2013-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis
Sponsor:
University Hospital, Toulouse
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-04
First Submit QC Date:
None
Study First Post Date:
2013-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-24
Last Update Post Date:
2020-08-25
Last Update Post Date Type:
ACTUAL